NEW YORK (GenomeWeb) – Exact Sciences and the Mayo Clinic announced today that they have expanded their collaboration to develop screening, surveillance, and diagnostic tests for colorectal cancer to include other diseases within the gastrointestinal tract.

"By expanding our relationship with Mayo Clinic, we have an opportunity to build on our shared successes and continue looking for new opportunities to take on some of the deadliest forms of cancer," Exact CEO and Chairman Kevin Conroy said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.